MEDICAMEQ302.00

Medicamen Biotech Limited

· Pharma & Health
₹ CrorePeersMEDICOAAREYDRUGSNECLIFEHALEOSLABSALBERTDAVDNATCAPSUQVALIANTLABBALPHARMAMcap ₹410 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Inventory Days (DIO)206.99250.20271.11271.11
Receivable Days (DSO)112.49154.71151.02151.02
Payable Days (DPO)158.34171.51154.77158.10
Cash Conversion Cycle (days)161.14233.40267.36264.03
Working Capital Turnover2.621.881.461.49
Asset Turnover0.610.550.530.53
Cash Conversion (CFO/Net Income)-0.04-1.10-3.39-3.39
CFO/EBITDA-0.02-0.52-1.69-1.69
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.